Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 2
2013 3
2014 2
2015 3
2016 3
2017 3
2018 8
2019 10
2020 7
2021 3
2022 6
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
[Diagnostic markers in urology].
Hupe MC, Hempel MC, Rodler S, Frantzi M, Mischak H, Merseburger AS, Stief CG, Chaloupka M. Hupe MC, et al. Among authors: frantzi m. Urologe A. 2021 Oct;60(10):1323-1330. doi: 10.1007/s00120-021-01568-8. Urologe A. 2021. PMID: 34156515 Review. German.
Proteomics and Metabolomics for AKI Diagnosis.
Marx D, Metzger J, Pejchinovski M, Gil RB, Frantzi M, Latosinska A, Belczacka I, Heinzmann SS, Husi H, Zoidakis J, Klingele M, Herget-Rosenthal S. Marx D, et al. Among authors: frantzi m. Semin Nephrol. 2018 Jan;38(1):63-87. doi: 10.1016/j.semnephrol.2017.09.007. Semin Nephrol. 2018. PMID: 29291763 Review.
Drug repurposing in oncology.
Frantzi M, Latosinska A, Mokou M, Mischak H, Vlahou A. Frantzi M, et al. Lancet Oncol. 2020 Dec;21(12):e543. doi: 10.1016/S1470-2045(20)30610-0. Lancet Oncol. 2020. PMID: 33271100 No abstract available.
Proteomics in Drug Development: The Dawn of a New Era?
Frantzi M, Latosinska A, Mischak H. Frantzi M, et al. Proteomics Clin Appl. 2019 Mar;13(2):e1800087. doi: 10.1002/prca.201800087. Epub 2019 Feb 25. Proteomics Clin Appl. 2019. PMID: 30724014 Review.
Promise and Implementation of Proteomic Prostate Cancer Biomarkers.
Latosinska A, Frantzi M, Merseburger AS, Mischak H. Latosinska A, et al. Among authors: frantzi m. Diagnostics (Basel). 2018 Aug 29;8(3):57. doi: 10.3390/diagnostics8030057. Diagnostics (Basel). 2018. PMID: 30158500 Free PMC article. Review.
Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.
Latosinska A, Frantzi M, Vlahou A, Merseburger AS, Mischak H. Latosinska A, et al. Among authors: frantzi m. Proteomics Clin Appl. 2018 Mar;12(2). doi: 10.1002/prca.201700074. Epub 2017 Oct 25. Proteomics Clin Appl. 2018. PMID: 28980455 Review.
Biomarkers for bladder cancer aggressiveness.
Frantzi M, Makridakis M, Vlahou A. Frantzi M, et al. Curr Opin Urol. 2012 Sep;22(5):390-6. doi: 10.1097/MOU.0b013e328356ad0e. Curr Opin Urol. 2012. PMID: 22825458 Review.
49 results